A groundbreaking study published in The Lancet has found that the integration of artificial intelligence (AI) into mammography screening can lead to a 12% reduction in the rate of late cancer diagnoses. The research, which involved 100,000 women in Sweden, demonstrated that AI-supported screening was more effective than standard reading by human radiologists in detecting breast cancers at an early stage.
The study used an AI system that analyzed mammograms and assigned low-risk cases to a single reading and high-risk cases to double readings by radiologists. The AI also highlighted suspicious findings to support radiologists, thereby ensuring accurate detection of cancerous tumors.
According to the researchers, more than 80% of cancers in the AI-supported group were detected during screening, compared to just under three-quarters in the control group. Moreover, there was a significant reduction in aggressive sub-type cancers in the AI group.
While the findings are promising, experts caution that introducing AI into healthcare must be done cautiously and with continuous monitoring to ensure its effectiveness. Dr. Kristina Lång, lead author of the study, emphasized the potential benefits of AI-supported mammography, including reduced workload pressures among radiologists and improved early detection of cancers.
However, another expert noted that there is a risk of missing some cancers due to the use of AI. Cancer Research UK's Senior Strategic Evidence Manager, Dr. Sowmiya Moorthie, highlighted the need for further research to confirm the findings.
Breast cancer remains a leading cause of death in women aged 35-50, with over 2 million people diagnosed globally each year. The study's results suggest that AI-supported mammography could be a vital tool in improving early detection and saving lives.
The study used an AI system that analyzed mammograms and assigned low-risk cases to a single reading and high-risk cases to double readings by radiologists. The AI also highlighted suspicious findings to support radiologists, thereby ensuring accurate detection of cancerous tumors.
According to the researchers, more than 80% of cancers in the AI-supported group were detected during screening, compared to just under three-quarters in the control group. Moreover, there was a significant reduction in aggressive sub-type cancers in the AI group.
While the findings are promising, experts caution that introducing AI into healthcare must be done cautiously and with continuous monitoring to ensure its effectiveness. Dr. Kristina Lång, lead author of the study, emphasized the potential benefits of AI-supported mammography, including reduced workload pressures among radiologists and improved early detection of cancers.
However, another expert noted that there is a risk of missing some cancers due to the use of AI. Cancer Research UK's Senior Strategic Evidence Manager, Dr. Sowmiya Moorthie, highlighted the need for further research to confirm the findings.
Breast cancer remains a leading cause of death in women aged 35-50, with over 2 million people diagnosed globally each year. The study's results suggest that AI-supported mammography could be a vital tool in improving early detection and saving lives.